Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,085-18,096 of 23,847
Drug study icon
CompletedNCT00841269

Oral Uridine for Treatment of Depression in bipolarity in Adolescents

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

In Salt Lake City
Bipolarity, DepressionDrugA study involving a medication or substance.From 13 Years to 18 Years
Countries
United States
Sponsor
University of Utah
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00330551

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

This study exists to compare options and see whether a guided support group offers something meaningfully different. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.

In Los Angeles
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00425815

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02663986

Organizational Skill Training (OST) in Schools

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In New York
ADHDBehavioralFrom 8 Years to 11 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
ADHD
Drug study icon
CompletedNCT02215538

OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Salt Lake City
ADHDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Utah
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.